期刊文献+

归脾汤加减配合米非司酮治疗功能失调性子宫出血46例临床观察 被引量:2

下载PDF
导出
摘要 目的观察归脾汤加减配合米非司酮治疗功能失调性子宫出血(简称功血)的临床疗效。方法将92例功血患者随机分为2组,对照组46例予米非司酮治疗,治疗组46例予归脾汤加减配合米非司酮治疗,2组均连续治疗30 d,观察3个月经周期后判定疗效。结果治疗组总有效率达100.00%,对照组为89.13%,2组比较差异有高度统计意义(P<0.01)。2组治疗后血清卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇(E2)、泌乳素(PRL)含量均较同组治疗前显著降低,比较差异有统计意义(P<0.05);治疗后治疗组各项指标显著低于对照组,2组比较差异有统计意义(P<0.05)。结论归脾汤加减配合米非司酮治疗功血疗效显著,且可显著降低患者血清FSH,LH,E2,PRL含量,值得在临床上推广。
作者 魏晓莉
出处 《甘肃中医学院学报》 2011年第5期27-29,共3页 Journal of Gansu College of Traditional Chinese Medicine
  • 相关文献

参考文献2

  • 1中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中华人民共和国卫生部制定发布,1993:143
  • 2李晓佳,安振梅,魏松全.OCIF/OPG的研究进展[J].国外医学(内分泌学分册),2000,20(1):1-4. 被引量:8

二级参考文献10

  • 1Yamaguchi K,Kinosaki M,Goto M,et al.Characterization of structural domain of human osteoclastogenesis inhibitory factor〔J〕[].Journal of Biological Chemistry.1998
  • 2Tsuda E,Goto M,Mochizuki S,et al.Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis〔J〕[].Biochemical and Biophysical Research Communications.1997
  • 3Morinaga T,Nakagawa N,Yasuda H,et al.Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor〔J〕[].European Journal of Biochemistry.1998
  • 4Lacey DL,Timms E,Tan TL,et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation〔J〕[].Cell.1998
  • 5Brandstrom H,Jonsson KB,Ohlsson C,et al.Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells 〔J〕[].Biochemical and Biophysical Research Communications.1998
  • 6Takai H,Kanematsu M,Yano K,et al.Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells〔J〕[].Journal of Biological Chemistry.1998
  • 7Yasuda H,Shima N,Nakagawa N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL〔J〕[].Proceedings of the National Academy of Sciences of the United States of America.1998
  • 8Hofbauer LC,Dunstan CR,Spelsberg TC,et al.Osteoprotegerin production by human osteoblast lineage cells in stimulated by vitamin D, bone morphogenetic protein-2, and cytokines 〔J〕[].Biochemical and Biophysical Research Communications.1998
  • 9Yasuda H,Shima N,Nakagawa N,et al.Identity of osteoclastogenesis inhibitory factor(OCIF)and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro〔J〕[].The Journal of Endocrinology.1998
  • 10Akatsy T,Murakami T,Nishikawa M,et al.Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast 〔J〕[].Biochemical and Biophysical Research Communications.1998

共引文献277

同被引文献31

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部